Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2008 Jan 28;7(2):823–836. doi: 10.1111/j.1750-3639.1997.tb01067.x

Neurofibromatosis 1 and 2

Ian F Pollack 1,3,✉, Jonn J Mulvihill 2,3
PMCID: PMC8098612  PMID: 9161732

Abstract

Neurofibromatosis (NF) 1 and 2 are multisystem disorders associated with a variety of neoplastic and non‐neoplastic manifestations that typically progress in severity during the lifetime of the affected patient. The importance of appropriately diagnosing these disorders stems from the fact that the natural history of an associated neoplasm, such as a peripheral nerve tumor or an optic glioma, may be significantly different depending on whether or not the lesion arises in a person with NF. In addition, the indications for therapeutic intervention, hierarchy of treatment options and long‐term management goals may differ substantially for patients with NF‐related versus sporadic tumors. Finally, recognition of the diagnosis comprises an essential step for providing appropriate multidisciplinary evaluation and counseling to affected patients and their families. This article addresses the principal manifestations of these disorders and provides a contemporary review of the diagnostic and therapeutic issues that arise in children with NF1 and NF2.

Full Text

The Full Text of this article is available as a PDF (5.8 MB).

References

  • 1. von Recklinghausen F. (1882) Ueber die multiplen fibrome der haut und ihre beziehung zu den multiplen neuromen. (Berlin. Hirschwald. [PubMed]
  • 2. Riccardi VM (1981) Von Recklinghausen neurofibromatosis. N Engl J Med 305: 1617–1627. [DOI] [PubMed] [Google Scholar]
  • 3. Huson, SM Harper, PS , Compston DAS (1988) Von Recklinghausen neurofibromatosis. A clinical and population study in southeast Wales. Brain 111:1355–1381. [DOI] [PubMed] [Google Scholar]
  • 4. Xu G., O'Connell P., Viskochil D., Cawthon R., Robertson N., Culver M., Dunn D., Stevens J., Gesteland R., White R., et al. (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599–608. [DOI] [PubMed] [Google Scholar]
  • 5. Ballester R., Marchuk D., Boguski M., Saulino A., Letcher R., Wigler M., Collins F. (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and IRA proteins. Cell 63: 851–859. [DOI] [PubMed] [Google Scholar]
  • 6. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J. (1992) Aberrant regulation of ras proteins In malignant tumors cells from type 1 neurofibromatosis patients. Nafure 356: 713–715. [DOI] [PubMed] [Google Scholar]
  • 7. Martuza RL, Eldridge R. (1988) Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 318: 684–688. [DOI] [PubMed] [Google Scholar]
  • 8. Rouleau GA, Seizinger BR, Wertelecki W., Haines JL, Superneau DW, Martuza RL, Gusella JF (1990) Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. Am J Hum Genet 46: 323–328. [PMC free article] [PubMed] [Google Scholar]
  • 9. Trofatter JA, MacCollin MM, Flutter JL, Murreil RR, Duyao MP, Parry DM, Eldridge R., Kiley, N. , Menon AG, Pulaski K., et al. (1993) A novel moesin‐, ezrin‐, radixin‐like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72: 791–800. [DOI] [PubMed] [Google Scholar]
  • 10. Mulvihill JJ (1990) Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Int Med 113: 39–52. [DOI] [PubMed] [Google Scholar]
  • 11. Blatt J., Jaffe R., Deutsch M., Adkins JC (1986) Neurofibromatosis and childhood tumors. Cancer 57: 1225–1229. [DOI] [PubMed] [Google Scholar]
  • 12. Matsui I., Tanimura M., Kobayashi N., Sawada T., Nagahara N., Akatsuka J. (1993) Neurofibromatosis type 1 and childhood cancer. Cancer 72: 2746–2754. [DOI] [PubMed] [Google Scholar]
  • 13. Sorensen SA, Mulvihill JJ, Nielsen A. (1986) Long‐term follow‐up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. New Engl J Med 314: 1010–1015. [DOI] [PubMed] [Google Scholar]
  • 14. National Institutes of Health Consensus Development Conference (1988) Neurofibromatosis. Arch Neurol 45: 575–578. [PubMed] [Google Scholar]
  • 15. Parry DM, Eldridge R., Kaiser‐Kupfer MI, Bouzas EA, Pikus A., Patronas N. (1994) Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet 52: 450–461. [DOI] [PubMed] [Google Scholar]
  • 16. Moss G., Green SH (1994) What is segmental neurofibromatosis Br J Derm 130: 106–110. [DOI] [PubMed] [Google Scholar]
  • 17. Isenberg JS, Mayer P., Butler W., Pfaff‐Amessi T., Persing JA (1994) Multiple recurrent benign schwannomas of deep and superficial nerves of the upper extremity: a new variant of segmental neurofibromatosis. Ann Plastic Surg 33: 659–663. [DOI] [PubMed] [Google Scholar]
  • 18. Louis DN, Ramesh V., Gusella JF (1995) Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 5: 163–172. [DOI] [PubMed] [Google Scholar]
  • 19. Upadhayaya M., Shaw DJ, Harper PS (1994) Molecular basis of neurofibromatosis type 1 (NF1): Mutation analysis and polymorphisms in the NF1 gene. Hum Mutat 4: 83–101. [DOI] [PubMed] [Google Scholar]
  • 20. Heim RA, Kam‐Morgan LNW, Binnie CG, Corns DD, Cayouette MC, Farber RA, Aylsworth AS, Silverman LM, Luce MC (1995) Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Molec Genet 4: 975–981. [DOI] [PubMed] [Google Scholar]
  • 21. Abuelo DN, Meryash DL (1988) Neurofibromatosis with fully expressed Noonan syndrome. Am J Med Genet 29: 937–941. [DOI] [PubMed] [Google Scholar]
  • 22. Zvulunov A., Barak Y., Metzker A. (1995) Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis. Arch Derm 131: 904–908. [PubMed] [Google Scholar]
  • 23. Brunner HG, Hulsebos T., Steijlen PM, der Kinderen DJrd, Steen A., Hamel BC (1993) Exclusion of the neurofibromatosis 1 locus in a family with inherited café‐au‐lait spots. Am J Med Genet 46: 472–474. [DOI] [PubMed] [Google Scholar]
  • 24. Pulst SM, Routeau GA, Manneau C. Sieo JP (1993) Familial meningioma is not allelic to neurofibromatosis 2. Neurology 43: 2096–2098. [DOI] [PubMed] [Google Scholar]
  • 25. Baser ME, Ragge NK, Riccardi VM, Janus T., Ganty B., Pulst SM (1996) Phenotypic variability in monozygotic twins with neurofibromatosis 2. Am J Med Genet 64: 563–657. [DOI] [PubMed] [Google Scholar]
  • 26. Lewis RA, Riccarai VM (1981) Von Recklinghausen neurofibromatosis: incidence of tris hamartomas. Ophthalmol 88: 348–354. [DOI] [PubMed] [Google Scholar]
  • 27. DiSimone RE, Berman AT, Schwentker EP (1988) Toe orthopedic manifestation of neurofibromatosis: a clinical experience and review of the literature. Clin Orthop 230: 277–283. [PubMed] [Google Scholar]
  • 28. Macfarlane R., Levin AV, WeksDerg R., Blase S., Ratka JT (1995) Absence of the greater spnenoid wing in neurofibromatosis type 1: congenital or accuired: case report. Neurosurgery 37: 129–133. [DOI] [PubMed] [Google Scholar]
  • 29. Winter RB, Moe JH, Bradford DS, Lonstem JE, Weber AH (1979) Spine deformity in neurofibromatosis ‐ a review of 102 patients. J Bone Joint Surg Am 61: 677–694. [PubMed] [Google Scholar]
  • 30. Stiiler CA, Chessels JM, Fitchett M. (1994) Neurofibromatosis and childhood leukemia/lymphoma: a population‐based UKCCSG study. Br J Cancer 70: 969–972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Mulvihill JJ (1994) Malignancy: epidemiologically associated cancers. In: The Neurofibromatoses: A pathogenetic and clinical overview. Huson SM, Hughes RAC, (eds), pp. 305–315, Chapman and Hall. Medical: New York . [Google Scholar]
  • 32. Mulvihill JJ, Parry DM, Pikus A., Kaiser‐Kupfer MI Eldridge R. (1990) Neurofibromatosis (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med 113: 39–52. [DOI] [PubMed] [Google Scholar]
  • 33. DiMario FJ, Ramsby G., Greenstein R., Dunham B. (1993) Neurofibromatosis type 1: Magnetic resonance imaging findings J Child Neurol 8: 32–39. [DOI] [PubMed] [Google Scholar]
  • 34. Itoh T., Magnaldi S., White RM, Denckla MB, Hofman K., Naidu S., Bryan RN (1994) Neurofibromatosis type‐1—The evolution of deep gray and white‐matter MR abnormalities. Am J Neurorad 15: 1513–1519. [PMC free article] [PubMed] [Google Scholar]
  • 35. Sevick RJ, Barkovich AJ, Edwards MSB, Koch T., Berg B., Lempert T. (1992) Evolution of white matter lesions in neurofibromatosis type 1: MR findings. AJR 159: 171–175. [DOI] [PubMed] [Google Scholar]
  • 36. Denckla MB, Hofman K., Mazzocco MMM, Melhem E., Reiss AL, Bryan RN, Harris EL, Lee J., Cox CS, Schuerholz LJ (1996) Relationship between T2‐weighted hyperintensities (unidentified bright objects) and lower IQs In children with neurofibromatosis‐1. Am J Med Genet (Neuropsych Genet) 67: 98–102. [DOI] [PubMed] [Google Scholar]
  • 37. Varnhagen CK, Lewin S., Das JP, Bowen R. Ma K., Klimek M. (1988) Neurofibromatosis and psychological processes. Dev Behav Pediatry. 257–265. [PubMed]
  • 38. Ferner RE, Chaudhuri R., Cox T., Hughes RA (1993) MRI in neurofibromatosis 1. The nature and evolution of increased T2‐weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psych 56: 492–495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Listernak R., Charrow J., Greenwald MJ, Esterly NB (1989) Optic gliomas in chiiaren with neurofibromatosis type 1. J Pediatr 114: 788–792. [DOI] [PubMed] [Google Scholar]
  • 40. Lewis RA, Gerson LP, Axelscn KA, Riccardi VM, Whitford RP (1984) Von Recklinghausen neurofibromatosis: II. Incidence of optic gliomata. Ophthalmology 91: 929–935. [DOI] [PubMed] [Google Scholar]
  • 41. Hoffman HJ, Humphreys RP, Drake JM, Rutka JT, Becker LE, Jenkin D., Greenberg M. (1993) Optic pathway/ hypothalamic gliomas: A dilemma in management. Pediatr Neurosurg 19: 186–195. [DOI] [PubMed] [Google Scholar]
  • 42. Dutton JJ (1994) Gliomas of the anterior visual pathway. Survey of Ophthalmology 38: 427–452. [DOI] [PubMed] [Google Scholar]
  • 43. Jenkin D., Angyalfi S., Becker L., Berry M., Buncic R., Chan H., Doherty M., Drake J., Greenberg M., Hendrick B., et al. (1993) Optic nerve glioma in children—surveillance, resection, or irradiation. Int J Rad Oncol Biol Phys 25: 215–225. [DOI] [PubMed] [Google Scholar]
  • 44. Pierce SM, Barnes PD, Loeffler JS, McGinn C., Tarbell NJ (1990) Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long‐term effects. Cancer 65: 45–52. [DOI] [PubMed] [Google Scholar]
  • 45. Listernick R., Charrow J., Greenwald M., Mets M. (1994) Natural history of optic pathway tumors in children with neurofibromatosis type‐1. A longitudinal study. J Pediatr 125:63–66. [DOI] [PubMed] [Google Scholar]
  • 46. Housepian EM, Chi TL (1993) Neurofibromatosis and optic pathways gliomas. J Neuro-oncol 15: 51–55. [DOI] [PubMed] [Google Scholar]
  • 47. Alvord EC Jr, Lofton S. (1988) Gliomas of the optic nerve or chiasm. Outcome by patient's age, tumor site, and treatment. J Neurosurg 68: 85–98. [DOI] [PubMed] [Google Scholar]
  • 48. Deliganis AV, Geyer JR, Berger MS (1996) Prognostic significance of type 1 neurofibromatosis (von Recklinghausen disease) in childhood optic glioma. Neurosurgery 38:1114–1119. [DOI] [PubMed] [Google Scholar]
  • 49. Wisoff JH, Abbott R., Epstein F. (1990) Surgical management of exophytic chiasmatic‐hypothalamic tumors of childhood. J Neurosurg 73: 661–667. [DOI] [PubMed] [Google Scholar]
  • 50. Sutton LN (1994) Surgery as part of the multidisciplinary management of visual pathway gliomas. Pediatr Neurosurg 21: 263. 7865414 [Google Scholar]
  • 51. Kovalic JJ, Grigsby PW, Shephard MJ, Fineberg BB, Thomas PR (1990) Radiation therapy for gliomas of the optic nerve and chiasm. Int J Radiat Oncol Biol Phys 18: 927–932. [DOI] [PubMed] [Google Scholar]
  • 52. Duffner PK, Cohen ME, Thomas PRM, Lansky SB (1985) The long‐term effects of cranial irradiation on the central nervous system. Cancer 56: 1841–1846. [DOI] [PubMed] [Google Scholar]
  • 53. Ellenberg L., McComb JG, Siegel S., Stowe S. (1987) Factors affecting intellectual outcome in pediatric brain tumor patients. Neurosurgery 21: 638–644. [DOI] [PubMed] [Google Scholar]
  • 54. Livesey EA, Hindmarsh PC, Brook CGD, Whitton AC, Bloom HJ, Tobias JS, Godlee JN, Britton J. (1990) Endocrine disorders following treatment of childhood brain tumours. Br J Cancer 61: 622–625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Dirks PB, Jay V., Becker LE, Drake JM, Humphreys RP, Hoffman HJ, Rutka JT (1994) Development of anaplastic changes in low‐grade astrocytomas of childhood. Neurosurgery 34: 68–78. [PubMed] [Google Scholar]
  • 56. Kestle JR, Hoffman HJ, Mock AR (1993) Moya moya phenomenon after radiation for optic glioma. J Neurosurg 79: 32–35. [DOI] [PubMed] [Google Scholar]
  • 57. Packer RJ, Sutton LN, Bilaniuk LT, Radcliffe J., Rosenstock JG, Siegel KR, Bunin GR, Savino PJ, Bruce DA, Schut L. (1988) Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: An update. Ann Neurol 23: 79–85. [DOI] [PubMed] [Google Scholar]
  • 58. Packer RJ, Lange B., Ater J., Nicholson HS, Allen J., Walker R., Pradoo M., Jakacki R., Reaman G., Needles MN, et al. (1993) Carboplatin and vincristine for recurrent and newly diagnosed low‐grade gliomas of childhood. J Clin Oncol 11: 850–856. [DOI] [PubMed] [Google Scholar]
  • 59. Petronio J., Edwards MSB, Prados M., Freyberger S., Rabbitt J., Silver P., Levin VA (1991) Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotnerapy. J Neurosurg 74: 701–708. [DOI] [PubMed] [Google Scholar]
  • 60. Ilgren EB, Kinnier‐Wilson LM, Stiller CA (1985) Gliomas in neurofibromatosis: a series of 89 cases with evidence for enhanced malignancy in associated cerebellar astrocytomas. Pathol Annu 20: 331–357. [PubMed] [Google Scholar]
  • 61. Grabb PA, Lunsford LD, Albright AL, Kondziolka D., Flickinger JC (1996) Stereotactic radiosurgery for glial neoplasms of childhood. Neurosurgery 38: 696–702. [PubMed] [Google Scholar]
  • 62. Sposto R., Ertel IJ, Jenkin RDT, Bolsel CP, Venes JL, Ortega JA, Evans AE, Wara W., Hammond D. (1989) The effectiveness of chemotherapy for treatment of highgrade astrocytoma in children: results of a randomized trial. J Neuro-oncol 7: 165–77. [DOI] [PubMed] [Google Scholar]
  • 63. Finlay JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR, Bertolone SJ, McGuire P., Cherlow JM, Tefft M., et al. (1995) Randomized phase III trial in childhood high‐grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight‐drugs‐in‐1‐day regimen. J Clin One 13: 112–123. [DOI] [PubMed] [Google Scholar]
  • 64. Pollack IF, Shultz B., Mulvihill JJ (1996) The management of brain stem gliomas in patients with neurofibromatosis‐1. Neurology 46: 1652–1660. [DOI] [PubMed] [Google Scholar]
  • 65. Cohen ME, Duffner PK, Heffner RR, Lacey DJ, Brecher M. (1986) Prognostic factors in brain stem gliomas. Neurology 36: 602–605. [DOI] [PubMed] [Google Scholar]
  • 66. Raffel C., McComb JG, Bodner S., Gilles FE (1989) Benign brain stem lesions in pediatric patients with neurofibromatosis: case reports. Neurosurgery 25: 959–964. [DOI] [PubMed] [Google Scholar]
  • 67. Molloy PT, Bilaniuk L., Needle M., Vaughn SN, Zackai E., Phillips PC (1994) Brain stem mass lesions in neurofibromatosis type‐1. A distinct clinical entity. Ann Neurol 36: 549 (abstract). [DOI] [PubMed] [Google Scholar]
  • 68. Pollack IF, Pang D., Albright AL (1994) The long‐term outcome in children with late‐onset aqueductal stenosis resulting from benign intrinsic tectal tumors. J Neurosurg 80: 681–88. [DOI] [PubMed] [Google Scholar]
  • 69. Russell DS, Rubinstein LJ (1977) Pathology of Tumours of the Nervcus System, 4th Ed. Baltimore : Williams and Wilkins, pp 293–297. [Google Scholar]
  • 70. Halliday AL, Sobel RA, Martuza RL (1991) Benign spinal nerve sheath tumors: the occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg 74: 248–253. [DOI] [PubMed] [Google Scholar]
  • 71. Harkin JC (1980) Differential diagnosis of peripheral nerve tumors. In: Management of Peripheral Nerve Lesions, Omer G., Spinner M., (eds), pp. 657–668, WB Saunders: Philadelphia . [Google Scholar]
  • 72. Donner TR, Voorhies RM, Kline DG (1994) Neural sheath tumors of major nerves. J Neurosurg 81: 362–373. [DOI] [PubMed] [Google Scholar]
  • 73. Burk DL Jr, Brunberg JA, Kanal E., Latchaw RE, Wolf GL (1987) Spinal and paraspinal neurofibromatosis: surface coil MR imaging at 1.5 TI. Radiology 162: 797–801. [DOI] [PubMed] [Google Scholar]
  • 74. DeSouza FM, Smith PE, Molony TJ (1979) Management of brachial plexus tumors. J Otolaryngol 8: 537–540. [PubMed] [Google Scholar]
  • 75. Kline DG, Judice DJ (1983) Operative management of selected brachial plexus lesions. J Neurosurg 58: 631–649. [DOI] [PubMed] [Google Scholar]
  • 76. Stevens JC, Davis DH, MacCarty CS (1983) A 32‐year experience with the surgical treatment of selected brachial plexus lesions with emphasis on its reconstruction. Surg Neurol 19: 334–345. [DOI] [PubMed] [Google Scholar]
  • 77. Bruckner HW, Gorbaty M., Lipsztein R., Kranjoi G., Liebwohl, MG (1992) Treatment of large high‐grade neurofibrosarcona with concomitant vinblastine, doxorubicin, and radiotherapy. Mt Sinai J Med 59: 429–432. [PubMed] [Google Scholar]
  • 78. Riccardi VM, Powell PP (1989) Neurofibrosarcoma as a complication of von Recklinghausen neurofibromatosis. Neurofibromatosis 2: 152–165. [PubMed] [Google Scholar]
  • 79. Richardson RR, Siquiera EB, Oi S., Nuney C. (1979) Neurogenic tumors of the brachial plexus: report of two cases. Neurosurgery 4: 66–70. [DOI] [PubMed] [Google Scholar]
  • 80. Lusk MD, Kline DG, Garcia CA (1987) Tumors of the orachial plexus. Neurosurgery 21: 439–453. [DOI] [PubMed] [Google Scholar]
  • 81. Schneider G., Korf B. (1986) Update on the experimental treatment trials. NNFF Worldwide NF Clinic Newsletter 3: 1. [Google Scholar]
  • 82. Yan N., Ricca C., Fletcher J., Giover T., Seizinger BR, Manne V. (1995) Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype. Cancer Res 55: 3569–3575. [PubMed] [Google Scholar]
  • 83. Schutheiss R., Gullotta G. (1993) Resection of relevant nerve roots in surgery of spinal neurinomas without persisting neurological deficit. Acta Neurochir (Wien) 122: 91–96. [DOI] [PubMed] [Google Scholar]
  • 84. Kim P., Ebersoid MJ Onofrio BM, Quast LM (1989) Spinal of spinal schwannoma. Risk of neurological deficit after resection of involved root. J Neurosurg 71: 810–814. [DOI] [PubMed] [Google Scholar]
  • 85. Maumer V‐F, Lindenau M., Baser ME, Hazim W., Tatagiba M., Haase W., Samii M., Wais R., Pulst SM (1996) The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery 38: 880–886. [DOI] [PubMed] [Google Scholar]
  • 86. Evans DG, Huson SM, Donnai D., Neary W., Blair V., Newton V., Harris R. (1992) A clinical study of type 2 neurofibromatosis. Quart J Med 84: 603–618. [PubMed] [Google Scholar]
  • 87. Black FO, Brackmann DE, Hitse berger WE, Purdy J. (1995) Preservation of auditory and vestibular function after surgical removal of bilateral vestibular schwannomas in a patient with neurofibromatosis type 2. Am J Otol 16: 431–443. [PubMed] [Google Scholar]
  • 88. Doyle KJ, Shelton C. (1993) Hearing preservation in bilateral acoustic neuroma surgery. Am J Otol 14: 562–565. [PubMed] [Google Scholar]
  • 89. Glasscock ME 3rd, Hart MJ, Vrabec JT (1992) Management of bilateral acoustic neuroma. Otolaryngol Clin N Am 25: 449–469. [PubMed] [Google Scholar]
  • 90. Brackmann DE, Hitselberger WE, Nelson RA, Moore J., Waring MD, Portillo F., Shannon RV, Teliochi FF (1993) Auditory brain stem implant: I. Issues in surgical implantation. Otolarygnol Head and Neck Surg 108: 624–633. [DOI] [PubMed] [Google Scholar]
  • 91. Hoffman RA, Kohan D., Cohen NL (1992) Cochlear implants in the management of bilateral acoustic neuromas. Am J Otol 13: 525–528. [PubMed] [Google Scholar]
  • 92. Pollock BE, Lunsford LK, Kondzioika D., Flickinger JC, Bissonette DJ, Kelsey SF, Jannetta PJ (1995) Outcome analysis of acoustic neuroma management: a comparison of microsurgery and stereotactic radiosurgery. Neurosurgery 36: 215–224. [DOI] [PubMed] [Google Scholar]
  • 93. Blomstedt GC, Jaaskelainen JE, Pyykko I., Ishizaki H., Troupp H., Palva T. (1994) Recovery of sutured facial nerve after removal of acoustic neuroma in patients with neurofibromatosis‐2. Neurosurgery 35: 364–368. [DOI] [PubMed] [Google Scholar]
  • 94. Evans DG, Ramsden R., Huson SM, Harris R., Lye R., King TT (1993) Type 2 neurofibromatosis: the need for supraregional care. J Laryngol Otol 107: 401–406. [DOI] [PubMed] [Google Scholar]
  • 95. Egelhoff JC, Bates DJ, Ross JS, Rother AD, Cohen BH (1992) Spinal MR findings in neurofibromatosis types 1 and 2. AJNR 13: 1071–1077. [PMC free article] [PubMed] [Google Scholar]
  • 96. Mautner V‐F, Tatagiba M., Guthoff R., Samii M., Pulst SM (1993) Neurofibromatosis 2 in the pediatric age group. Neurosurgery 33: 92–96. [DOI] [PubMed] [Google Scholar]
  • 97. Lee M., Rezal AR, Freed D., Ebstein HJ (1996) Intramedullary spinal cord tumors in neurofibromatosis. Neurosurgery 38: 32–37. [DOI] [PubMed] [Google Scholar]
  • 98. Seashore MR, Cho S., Desposito F., Wappner RS, Wilson MG (1995) Health supervision for children with neurofibromatosis. Pediatrics 96: 368–372. [PubMed] [Google Scholar]
  • 99. Pollack IF, Mulvihill JJ (1997) Neurofibromatosis In: Principals and Practice of Pediatric Neurosurgery, (eds)Albright AL, Pollack IF, Adelson PD, Triemei New York (in press).

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES